Hello TLPEQ board, Its been awhile since I have posted on here.
I noticed that Marius Silvasan just filed a form 15-12b for One Bio corp.
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
This is interesting because Marius Silvasan and Abacus Global Investments were hired to take the private company Sanming Hujian Bioengineering public in 2008. That’s how he became CEO of ONBI, (new ticker ONBIE.)
MIAMI, FL – June 24th, 2008 – Abacus World, Corp. (www.abacusworldcorp.com) (“Abacus” or the “Company”), a business advisory firm catered to help small and midsized companies reach their full potential, announced that it has entered into an agreement with Sanming Hujian Bioengineering Co., LTD (“Sanming”) to provide certain services.
As part of the agreement, Abacus is to provide services which include, but are not limited to, bringing Sanming public in the United States, providing general consulting and advisory services, and introducing Sanming to institutional investors and high net worth individuals to raise capital for growth.
If Min Zhao Sanming doesn’t want to be a publically traded company anymore, It could mean that Silvasan will step down as CEO and pursue other endeavors.
In late 2011 he and his wife filed Articles of Incorporation for three different companies.
Connect Link, Silvasan Global Fund and TFP International.
Market Data 
Markets 
AI
